The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Australasian Gastrointestinal Trials Group (AGITG) CONTROL NET Study: 177Lu-DOTATATE peptide receptor radionuclide therapy (PRRT) and capecitabine plus temozolomide (CAPTEM) for pancreas and midgut neuroendocrine tumours (pNETS, mNETS)—Final results.
 
Nick Pavlakis
Consulting or Advisory Role - Amgen; AstraZeneca; Beigene; Boehringer Ingelheim; Bristol-Myers Squibb; Eisai; Merck KGaA; Merck Serono; Merck Sharp & Dohme; Novartis; Pfizer; Roche; Takeda
Research Funding - Bayer (Inst); Pfizer (Inst); Roche (Inst)
 
David Turner Ransom
Travel, Accommodations, Expenses - Ipsen
 
David Wyld
Consulting or Advisory Role - Ipsen; Novartis; Novartis
Speakers' Bureau - Ipsen
Research Funding - Ipsen (Inst); Ipsen (Inst); Ipsen (Inst)
Travel, Accommodations, Expenses - Ipsen; Ipsen; MSD Oncology; Novartis; Novartis; Novartis
 
Katrin Marie Sjoquist
Honoraria - AMGEN; BMS; Ipsen; Merck; Merck; SERVIER
Consulting or Advisory Role - Competitive Drug Development International
Research Funding - Bayer (Inst)
 
Kate Wilson
No Relationships to Disclose
 
Val Gebski
No Relationships to Disclose
 
James Murray
No Relationships to Disclose
 
Andrew Ddembe Kiberu
No Relationships to Disclose
 
Matthew E. Burge
Stock and Other Ownership Interests - Bristol-Myers Squibb; coclear; CSL Limited; Gilead Sciences; pfizer
Honoraria - Amgen; Bristol Myers squibb; Merck KGaA; Merck Sharp & Dohme; SERVIER
Consulting or Advisory Role - Amgen; ipsen; merck srpe Dohme; Roche; SERVIER
Speakers' Bureau - Merck Sharpe Dohme
Research Funding - Amgen (Inst)
Patents, Royalties, Other Intellectual Property - funding for an investigator initiated prospective trial (Inst)
 
William Macdonald
No Relationships to Disclose
 
Paul Roach
No Relationships to Disclose
 
David A. Pattison
No Relationships to Disclose
 
Patrick Butler
No Relationships to Disclose
 
Timothy Jay Price
Honoraria - SERVIER
Consulting or Advisory Role - Amgen (Inst); AstraZeneca (Inst); BMS (Inst); Merck
Research Funding - AMGEN (Inst)
Travel, Accommodations, Expenses - Amgen
 
Michael Michael
Honoraria - Novartis; SAM NORDIC
Consulting or Advisory Role - Ipsen; Isotopen Technologien; MDS; Merck; PanTher Therapeutics
Research Funding - Ipsen
Travel, Accommodations, Expenses - Ipsen; Ipsen; Novartis
 
Benjamin James Lawrence
No Relationships to Disclose
 
Dale L. Bailey
Employment - GenesisCare
Consulting or Advisory Role - Clarity Pharmaceuticals
Research Funding - Ipsen (Inst); Varian Medical Systems (Inst)
 
Simone Leyden
No Relationships to Disclose
 
John Raymond Zalcberg
Stock and Other Ownership Interests - Amarin Corporation; Biomarin; Concert Pharmaceuticals; Frequency Therapeutics; Gilead Sciences; Madrigal Pharmaceuticals; Moderna Therapeutics; Novavax; Opthea; Orphazyme; Twist Bioscience; UniQure; Zogenix
Honoraria - Deciphera; Gilead Sciences; Halozyme; Merck Serono; Specialised Therapeutics; Targovax
Consulting or Advisory Role - 1Globe Health Institute; Center for Emerging & Neglected Diseases (CEND); Deciphera; FivePHusion; Genor BioPharma; Halozyme; Lipotek; Merck Serono; Merck Sharp & Dohme; Novotech; Revolution Medicines; Specialised Therapeutics; Targovax
Research Funding - AstraZeneca (Inst); Bristol-Myers Squibb (Inst); Eisai (Inst); Ipsen (Inst); IQvia (Inst); Medtronic (Inst); Merck Serono (Inst); MSD Oncology (Inst); Mylan (Inst); Pfizer (Inst)
Travel, Accommodations, Expenses - AstraZeneca; Deciphera; Merck Serono; Merck Sharp & Dohme; Sanofi
 
Harvey Turner
No Relationships to Disclose